1. Indications for Adjuvant Mediastinal Radiotherapy in Surgically Resected Small Cell Lung Cancer 
Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B. Leighl, MD, MS, Samuel R.G. Finlayson, MD, MPH, Thomas K. Varghese, MD, MS, Gail E. Darling, MD 
The Annals of Thoracic Surgery 
Volume 103, Issue 5, Pages (May 2017)
DOI: /j.athoracsur
Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

2. The Annals of Thoracic Surgery 2017 103, 1647-1653DOI: (10. 1016/j
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

3. Fig 1
Kaplan-Meier survival curves stratified by pathologic nodal stage: (A) all patients (log-rank [LR] test p = 0.15); (B) pathologic N0 (LR test p = 0.41); (C) pathologic N1 (LR test p = 0.008); and (D) pathologic N2 (LR test p < ). (AMR = adjuvant mediastinal radiotherapy; CI = confidence interval.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

4. Fig 2
Subpopulation analysis. Kaplan-Meier survival curves, stratified by procedure, for node- and margin-negative patients: (A) lobectomy (log-rank test p = 0.25), and (B) sublobar resections (log-rank test p = 0.08). (AMR = adjuvant mediastinal radiotherapy; CI = confidence interval.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions